AU2013903572A0 - Compositions for the treatment of hypertension and/or fibrosis - Google Patents
Compositions for the treatment of hypertension and/or fibrosisInfo
- Publication number
- AU2013903572A0 AU2013903572A0 AU2013903572A AU2013903572A AU2013903572A0 AU 2013903572 A0 AU2013903572 A0 AU 2013903572A0 AU 2013903572 A AU2013903572 A AU 2013903572A AU 2013903572 A AU2013903572 A AU 2013903572A AU 2013903572 A0 AU2013903572 A0 AU 2013903572A0
- Authority
- AU
- Australia
- Prior art keywords
- fibrosis
- hypertension
- compositions
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010016654 Fibrosis Diseases 0.000 title 1
- 206010020772 Hypertension Diseases 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020167009836A KR101863708B1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
AU2014324075A AU2014324075B2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
MX2016003372A MX368011B (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis. |
NZ717930A NZ717930A (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
SG11201601641VA SG11201601641VA (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
UAA201602269A UA117254C2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
JP2016515427A JP6293266B2 (en) | 2013-09-17 | 2014-09-17 | Composition for the treatment of hypertension and / or fibrosis |
DK14845828.4T DK3046902T3 (en) | 2013-09-17 | 2014-09-17 | COMPOSITIONS FOR TREATING HYPERTENSION AND / OR FIBROSE |
CN201480050947.1A CN105683153B (en) | 2013-09-17 | 2014-09-17 | composition for treating hypertension and/or fibrosis |
PCT/AU2014/000922 WO2015039172A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
ES14845828.4T ES2694375T3 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and / or fibrosis |
BR112016005606-0A BR112016005606B1 (en) | 2013-09-17 | 2014-09-17 | COMPOUND, PHARMACEUTICAL COMPOSITION, AND USES OF A COMPOUND |
CA2924353A CA2924353C (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
US15/022,264 US9630935B2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
MYPI2016000481A MY191337A (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
EP14845828.4A EP3046902B1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
RU2016112053A RU2661878C2 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
AP2016009080A AP2016009080A0 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
PH12016500495A PH12016500495B1 (en) | 2013-09-17 | 2016-03-14 | Compositions for the treatment of hypertension and/or fibrosis |
IL244622A IL244622A0 (en) | 2013-09-17 | 2016-03-16 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2013903572A0 true AU2013903572A0 (en) | 2013-10-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3038610A4 (en) | Compositions and methods for the treatment of presbyopia | |
EP2877159B8 (en) | Efflux inhibitor compositions and methods of treatment using the same | |
EP3030266A4 (en) | Topical compositions and methods of using the same | |
EP2991658A4 (en) | Antimicrobial compositions and methods of making the same | |
EP3071215A4 (en) | Compositions and methods for treating pulmonary hypertension | |
EP3102555A4 (en) | Compositions of compounds and uses thereof | |
EP3102200A4 (en) | Therapeutic compounds and compositions | |
EP3179983A4 (en) | Anti-methanogenic compositions and uses thereof | |
EP3166892A4 (en) | Scale-inhibition compositions and methods of making and using the same | |
EP3021839A4 (en) | Methods and compositions for treatment of fibrosis | |
EP2983681A4 (en) | Therapeutic compositions and uses thereof | |
EP3013364A4 (en) | Tuberculosis compositions and methods of using the same | |
EP3004396A4 (en) | Methods and compositions for the treatment of cancer | |
IL244621A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
IL244622A0 (en) | Compositions for the treatment of hypertension and/or fibrosis | |
EP3117827A4 (en) | Composition for vagina and use of the composition | |
HK1220374A1 (en) | Compositions and methods for the treatment of carboxyhemoglobinemia | |
EP3316871A4 (en) | Talc-bound compositions and uses thereof | |
EP3341006A4 (en) | Compositions and methods for the treatment of neurodamage | |
EP3165221A4 (en) | Blood-fat reducing composition and application thereof | |
EP3113774A4 (en) | Compositions of grapiprant and methods for using the same | |
EP3110435A4 (en) | Methods and compositions for the delayed treatment of stroke | |
EP2994147A4 (en) | Compositions and methods for the treatment of tinnitus | |
EP3038596A4 (en) | Compositions and methods for the removal of tattoos | |
EP3068431A4 (en) | Methods and compositions for the treatment of hcmv |